Maricel Agop | Biophysics | Best Researcher Award

Posted on by Physicist Particle

Prof Dr. Maricel Agop | Biophysics | Best Researcher Award

Google Scholar Profile

Educational Details

Prof. Dr. Maricel Agop has an impressive academic background, marked by significant achievements in physics. He earned his PhD in Physics from the Faculty of Physics “Al. I. Cuza” in Iași in 1983. His educational journey began with exceptional performance at the same faculty, where he specialized in “Solid Body for Research Institutes” and graduated at the top of his class with an average of 9.98. In 2013, he was honored with the Doctoral degree “HONORIS CAUSA” from the University “Vasile Alecsandri” in Bacău. Dr. Agop’s early education includes attendance at George Bacovia Theoretical High School in Bacău and Elementary School no. 5, laying a strong foundation for his illustrious career in academia and research.

 

Professional Experience:

Prof. Dr. Maricel Agop is a distinguished physicist with a long academic career at multiple Romanian institutions. Since 1997, he has served as a Professor of Physics at “Gheorghe Asachi” Technical University of Iași. He is also an Associate Professor and Ph.D. supervisor at “Al. I. Cuza” University of Iași since 2002, and holds a similar role at “Vasile Alecsandri” University of Bacău since 2011, where he is a member of the Doctoral School. His earlier experience includes roles as a physicist at the Institute of Energetic Nuclear Reactors and the Romanian Academy’s Iași Branch. Dr. Agop has been actively contributing to the field of physics since the 1980s, with a focus on both academic and research endeavors.

Awards and Honors:

Prof. Dr. Maricel Agop has been recognized with numerous prestigious awards throughout his career. He received the Prize of Excellence from the Union of Armenians in Romania (1995) and was named Doctor Honoris Causa by “Vasile Alecsandri” University of Bacău (2013). He is also a Corresponding Member of the Romanian Academy of Scientists (since 2018). Among his accolades are Romanian Academy Awards for his contributions to scale relativity physics and radiomics, as well as international recognition, including an “Honorable Mention” from the American Gravity Research Foundation (1986) and two gold medals at Brussels Eureka ’94 for his inventions.

Top Notable Publications

S. Gurlui, M. Agop, P. Nica, M. Ziskind, C. Focsa (2008). “Experimental and theoretical investigations of a laser-produced aluminum plasma,” Physical Review E, 78(2). 137 citations.

I. Merches, M. Agop (2015). “Differentiability and fractality in dynamics of physical systems,” World Scientific. 131 citations.

S. Bungau, D.M. Tit, K. Fodor, G. Cioca, M. Agop, C. Iovan, D.C.N. Cseppento, et al. (2018). “Aspects regarding the pharmaceutical waste management in Romania,” Sustainability, 10(8), 2788. 105 citations.

C. Bujoreanu, F. Nedeff, M. Benchea, M. Agop (2017). “Experimental and theoretical considerations on sound absorption performance of waste materials including the effect of backing plates,” Applied Acoustics, 119, 88-93. 104 citations.

P. Nica, P. Vizureanu, M. Agop, S. Gurlui, C. Focsa, N. Forna, P.D. Ioannou, et al. (2009). “Experimental and theoretical aspects of aluminum expanding laser plasma,” Japanese Journal of Applied Physics, 48(6R), 066001. 64 citations.

G.V. Munceleanu, V.P. Paun, I. Casian-Botez, M. Agop (2011). “The microscopic-macroscopic scale transformation through a chaos scenario in the fractal space-time theory,” International Journal of Bifurcation and Chaos, 21(02), 603-618. 60 citations.

E.S. Bacaita, B.C. Ciobanu, M. Popa, M. Agop, J. Desbrieres (2014). “Phases in the temporal multiscale evolution of the drug release mechanism in IPN-type chitosan based hydrogels,” Physical Chemistry Chemical Physics, 16(47), 25896-25905. 59 citations.

M. Agop, N. Forna, I. Casian-Botez, C. Bejenariu (2008). “New theoretical approach of the physical processes in nanostructures,” Journal of Computational and Theoretical Nanoscience, 5(4), 483-489. 58 citations.

M. Agop, V.P. Păun (2017). “On the New Perspectives of Fractal Theory: Fundaments and Applications,” Editura Academiei Române. 56 citations.

C. Focsa, S. Gurlui, P. Nica, M. Agop, M. Ziskind (2017). “Plume splitting and oscillatory behavior in transient plasmas generated by high-fluence laser ablation in vacuum,” Applied Surface Science, 424, 299-309. 55 citations.

 

 

 

 

 

 

 

Antonios Kolocouris | Computational Biophysics | Best Researcher Award

Posted on by Physicist Particle

Prof. Antonios Kolocouris | Computational Biophysics | Best Researcher Award

Professor Antonios Kolocouris is a faculty member in the Department of Pharmaceutical Chemistry at the Faculty of Pharmacy, National and Kapodistrian University of Athens. He is an expert in medicinal chemistry, focusing on the design and synthesis of antiviral agents, particularly targeting influenza and coronaviruses. His research includes structure-based drug design and molecular modeling, aiming to discover new therapeutics for viral infections. Prof. Kolocouris has authored numerous publications in peer-reviewed journals and has been involved in international collaborations to advance pharmaceutical science and antiviral drug development.

PROFILE

Scopus Profile

Orcid Profile

Educational Details

Professor Antonios Kolocouris earned his degree in Chemistry (MSc equivalent) from the National and Kapodistrian University of Athens (NKUA) in 1989, graduating with distinction (8.6/10). He pursued his PhD in Medicinal Chemistry at the Laboratory of Medicinal Chemistry, Department of Pharmacy, NKUA, from 1990 to 1995. Following his doctoral work, he conducted post-doctoral research at the same institution in 1997, focusing on synthetic medicinal chemistry. From 1997 to 2000, Prof. Kolocouris served as a post-doctoral researcher at the Laboratory of Molecular Biophysics, Institute of Chemical Biology, National Hellenic Research Foundation. His research there involved studying the conformation of Angiotensin II and its agonists and antagonists using NMR spectroscopy and molecular dynamics (MD) simulations, as well as the interactions of drug-lipid conjugates like AZT with model membranes. He also contributed to the structure elucidation of natural products using various biophysical methods.

Academic Positions:

Professor Antonios Kolocouris has had a distinguished academic career at the National and Kapodistrian University of Athens (NKUA), where he has been a faculty member in the Department of Pharmaceutical Chemistry. He began his tenure as a Lecturer in October 2000, advancing to Assistant Professor in April 2006. In March 2010, he secured tenure as an Assistant Professor in the Laboratory of Medicinal Chemistry. By May 2011, he was promoted to Associate Professor, and in May 2020, he attained the rank of full Professor. Throughout his career, Prof. Kolocouris has made significant contributions to the field of medicinal chemistry, particularly in drug design and development.

Research Visits: 

Professor Antonios Kolocouris has engaged in numerous international research collaborations throughout his career, contributing to advancements in medicinal chemistry and drug design. In September 1999, he conducted dynamic NMR studies on hindered ring inversion and nitrogen inversion at University College London’s Department of Chemistry. In 2002 and 2004, at the University of Cambridge’s Department of Biochemistry, he utilized NMR and 19F NMR techniques to study the interactions of aminoadamantanes with influenza A M2 protein in liposomes and micelles. His work on docking calculations and molecular dynamics (MD) simulations continued at the University of Pisa in 2008 and 2009, focusing on aminoadamantane interactions with the influenza A M2 protein using AMBER software. In 2010, at the University of Zurich’s Department of Biochemistry, he applied MM-PBSA and LIE calculations with the CHARMM force field. His research expanded to include MM-PBSA calculations with AMBER at the University of Düsseldorf in 2012, deepening his exploration of influenza A M2 protein interactions with aminoadamantanes.

Research Activity:

Professor Antonios Kolocouris specializes in medicinal chemistry with a focus on membrane protein-ligand interactions. His research employs molecular dynamics (MD) simulations and advanced free energy calculation methods, including MM-PBSA, FEP/MD, and TI/MD, as well as NMR spectroscopy, to study these interactions in detail. He is also experienced in virtual screening of chemical libraries, using both structure-based and ligand-based approaches to identify potential bioactive compounds. Additionally, his work emphasizes the development of structure-activity relationships (SAR) and 3D quantitative structure-activity relationships (3D QSAR) to optimize ligand efficacy. His expertise extends to the chemical synthesis of bioactive ligands, further contributing to the field of drug discovery and design.

Research Areas:

Professor Antonios Kolocouris has conducted extensive research on the interactions of aminoadamantanes with the influenza A M2 protein, employing a variety of methods including NMR spectroscopy, ITC, electrophysiology, ssNMR, DSC, and antiviral assays. His studies have focused on both wild-type and amantadine-resistant strains of influenza A, utilizing molecular dynamics (MD) simulations and binding free energy calculations (FEP/MD, TI/MD, MM-PB(GB)SA) since 2002. Additionally, he has applied computational drug design techniques and synthesized aminoadamantanes and polar head heterocycle conjugates to combat these strains. His work in structure-based drug design includes virtual screening of chemical libraries for bioactive molecules targeting Adenosine Receptors, leading to the development of new selective antagonists. He has also mapped the orthosteric binding area of A3AR through mutagenesis, kinetic studies, and computational approaches. More recently, Prof. Kolocouris has focused on designing and synthesizing SQ109 analogues to inhibit the Mmpl3 bacterial transporter for treating neglected diseases, alongside earlier work on peptide conformational analysis using MD simulations and NOE experiments.

Top Notable Publications

Huang, X., Chorianopoulou, A., Kalkounou, P., Lougiakis, N., Ladds, G. (2024). “Hit-to-Lead Optimization of Heterocyclic Carbonyloxycarboximidamides as Selective Antagonists at Human Adenosine A3 Receptor.” Journal of Medicinal Chemistry, 67(15), 13117–13146.

Zorba, L.P., Stylianakis, I., Tsoureas, N., Kolocouris, A., Vougioukalakis, G.C. (2024). “Copper-Catalyzed One-Pot Synthesis of Thiazolidin-2-imines.” Journal of Organic Chemistry, 89(11), 7727–7740.

Stampelou, M., Ladds, G., Kolocouris, A. (2024). “Computational Workflow for Refining AlphaFold Models in Drug Design Using Kinetic and Thermodynamic Binding Calculations: A Case Study for the Unresolved Inactive Human Adenosine A3 Receptor.” Journal of Physical Chemistry B, 128(4), 914–936.

Georgiou, K., Konstantinidi, A., Hutterer, J., Gauglitz, G., Kolocouris, A. (2024). “Accurate Calculation of Affinity Changes to the Close State of Influenza A M2 Transmembrane Domain in Response to Subtle Structural Changes of Adamantyl Amines Using Free Energy Perturbation Methods in Different Lipid Bilayers.” Biochimica et Biophysica Acta – Biomembranes, 1866(2), 184258.

Watson, S.J., van der Watt, M.E., Theron, A., Oldfield, E., Birkholtz, L.-M. (2024). “The Tuberculosis Drug Candidate SQ109 and Its Analogs Have Multistage Activity against Plasmodium falciparum.” ACS Infectious Diseases.

Stylianakis, I., Zervos, N., Lii, J.-H., Pantazis, D.A., Kolocouris, A. (2023). “Conformational Energies of Reference Organic Molecules: Benchmarking of Common Efficient Computational Methods Against Coupled Cluster Theory.” Journal of Computer-Aided Molecular Design, 37(12), 607–656.

Stylianakis, I., Zervos, N., Lii, J.-H., Pantazis, D.A., Kolocouris, A. (2023). “Correction to: Conformational Energies of Reference Organic Molecules: Benchmarking of Common Efficient Computational Methods Against Coupled Cluster Theory.” Journal of Computer-Aided Molecular Design, 37(12), 657.

Tan, B., Liu, C., Li, K., Liu, W., Wang, J. (2023). “Structure-Based Lead Optimization of Enterovirus D68 2A Protease Inhibitors.” Journal of Medicinal Chemistry, 66(21), 14544–14563.

Stampolaki, Μ., Hoffmann, A., Tekwani, K., Schmidtke, M., Kolocouris, A. (2023). “A Study of the Activity of Adamantyl Amines Against Mutant Influenza A M2 Channels Identified a Polycyclic Cage Amine Triple Blocker, Explored by Molecular Dynamics Simulations and Solid-State NMR.” ChemMedChem, 18(16), e202300182.